Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

NCT00968435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

OTHER: bevacizumab, cisplatin, cetuximab, radiation therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]